These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32445596)
1. Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein. Mahmoudi Z; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S APMIS; 2020 Jul; 128(7):476-483. PubMed ID: 32445596 [TBL] [Abstract][Full Text] [Related]
2. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection. Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813 [TBL] [Abstract][Full Text] [Related]
3. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb. Garg N; Singh R; Shukla G; Capalash N; Sharma P Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015 [TBL] [Abstract][Full Text] [Related]
4. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591 [TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469 [TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii. Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283 [TBL] [Abstract][Full Text] [Related]
7. Immunoprotectivity of Valine-glycine repeat protein G, a potent mediator of pathogenicity, against Acinetobacter baumannii. Pazoki M; Darvish Alipour Astaneh S; Ramezanalizadeh F; Jahangiri A; Rasooli I Mol Immunol; 2021 Jul; 135():276-284. PubMed ID: 33940514 [TBL] [Abstract][Full Text] [Related]
8. Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model. Naghipour Erami A; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S Microb Pathog; 2021 Dec; 161(Pt B):105291. PubMed ID: 34798280 [TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii. Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice. Guo SJ; Ren S; Xie YE Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195 [TBL] [Abstract][Full Text] [Related]
11. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716 [TBL] [Abstract][Full Text] [Related]
12. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection. Aghajani Z; Rasooli I; Mousavi Gargari SL APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768 [TBL] [Abstract][Full Text] [Related]
13. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii. Singh R; Capalash N; Sharma P Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492 [TBL] [Abstract][Full Text] [Related]
14. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590 [TBL] [Abstract][Full Text] [Related]
15. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723 [TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. McConnell MJ; Rumbo C; Bou G; Pachón J Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection. Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011 [TBL] [Abstract][Full Text] [Related]
19. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A. Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426 [TBL] [Abstract][Full Text] [Related]